China insurance Report Interpretation

Overview

Citi’s 1H26 China insurance results wrap finds healthy life-insurance new-business value growth, improved P&C underwriting profitability, and earnings and dividend gains supported by investment returns. The report expects near-term growth pressure in 3Q26 but remains constructive on the sector’s longer-term structural opportunity.

Core views

Life insurers recorded broadly decent 1H26 new business value (NBV) growth, although the drivers differed by company. China Life led at 34% year on year, followed by CPIC at 13%, New China Life at 12%, Ping An at 11%, PICC Life at 4% and Taiping Life at 1%. China Life benefited from both sales and margin expansion, including 38% agency-channel NBV growth, while Ping An had stronger bancassurance NBV growth. CPIC, New China Life and PICC Life mainly relied on margin improvement despite first-year-premium contraction. Contractual service margin growth was also positive, led by PICC Life and New China Life at 7% half on half and China Life at 6%; embedded value grew most at PICC Life, up 19% half on half. Citi expects life insurers to face a more difficult 2H26, particularly in 3Q26, because sales had been accelerated before the 3Q25 pricing-rate-cap cut and because further bancassurance expense rationalization since July 2026 has disrupted business in the short term. Nonetheless, the report argues that the longer-run growth opportunity remains intact as households structurally reallocate wealth toward insurance products. P&C premium growth was modest amid soft new-vehicle sales: Ping An, PICC and CPIC P&C reported growth of 4%, 1% and 1% year on year, respectively. Underwriting profitability improved further. PICC P&C’s combined ratio improved 0.8 percentage points to 94.0%, producing another historic high in underwriting profit; CPIC and Ping An P&C improved to 95.0% and 95.1%. ZhongAn improved 0.1 percentage point to 95.5%, while Taiping Insurance’s ratio deteriorated 1.3 percentage points to 98.0%. Citi attributes the broader improvement to regulator-driven expense rationalization and improved business mix. It expects potentially higher natural-catastrophe losses in 2H26 amid El Niño, but considers the full-year effect manageable because of risk prevention, reinsurance and continuing regulatory support for auto and non-auto lines. Sector earnings and shareholder returns strengthened in 1H26, primarily due to higher mark-to-market investment gains during the 2Q26 A-share rally. Earnings rose 229% at China Life, 90% at China Taiping, 54% at New China Life, 40% at PICC Group, 36% at Ping An, 32% at PICC P&C, 15% at China Re and 10% at CPIC. Net investment yields fell by 0.1 percentage point at China Life to 0.7 percentage point at Ping An, ending at 2.4%-3.1%, while total investment yields increased by 0.2 percentage point at CPIC to 4.5 percentage points at China Life, reaching 4.2%-8.2%. China Life, Ping An and CPIC reported operating-profit-after-tax growth of 13%, 8% and 6%; China Life’s dividend per share rose 50%, PICC Group’s and PICC P&C’s rose 47% and 42%, Ping An’s rose 3%, and CPIC introduced an interim dividend. Within the report’s detailed China Taiping Insurance update, Citi raised FY26E/FY27E/FY28E EPS by 39%/23%/13% to reflect higher investment-return assumptions and lifted its target price to HK$23.00 from HK$22.50. It retained a Neutral rating because the shares appeared fairly valued after the recent rally, despite robust growth in the life business. The HK$23 target uses a sum-of-the-parts approach: a three-stage NBV growth model, P&C at 0.6x fair P/B after the combined-ratio improvement, reinsurance at 0.5x book value, other operations at 0.5x book value, and a 15% holding-company discount. The target implies 0.4x 2026E P/EV.

Analysis framework

Citi compares insurers’ 1H26 NBV, first-year-premium, margin, contractual service margin, embedded value, premium growth, combined ratio, earnings, investment yields and dividends. It then links the results to regulatory expense rationalization, vehicle-sales conditions, investment-market gains and anticipated 3Q26 base effects. For China Taiping, it updates earnings assumptions and values the group with a sum-of-the-parts framework.

Methodology notes

• Valuation methodsSOTP (Sum-of-the-Parts) Valuation

  Sum-of-the-parts valuation for China Taiping Insurance

  Citi values the life, P&C, reinsurance and other operations separately, then applies a 15% holding-company discount to derive its HK$23 target price.

• Valuation methodsPB valuation

  Price-to-book multiples for China Taiping’s P&C, reinsurance and other operations

  The report applies P/B-based values, including a 0.6x fair P/B for P&C to reflect the improved combined ratio and 0.5x book value for reinsurance and other operations.

• Valuation methodsP/EV insurance valuation

  2026E price-to-embedded-value reference

  Citi states that its HK$23 China Taiping target implies 0.4x 2026E P/EV.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• China Taiping Insurance (0966.HK)

  Detailed company valuation update within the China insurance results wrap.

  Strengths

  Robust life-business growth; higher investment-return assumptions; improved P&C valuation reflecting combined-ratio progress.

  Weaknesses

  Citi considers the shares fairly valued after the recent rally.

  Comparison

  Reinsurance is valued at 0.5x book, at a discount to PICC’s 1.3x multiple because it is a smaller player.

  Risks

  Bond-yield declines, an A-share correction, earnings or NBV disappointment, slower life-business recovery, weaker execution after management changes, slower expansion, and severe catastrophe losses.

• PICC Group / PICC P&C

  Tactically preferred counter-cyclical names in Citi’s sector view.

  Strengths

  PICC P&C achieved a 94.0% combined ratio and a 0.8 percentage-point improvement, while PICC Group/P&C interim DPS rose 47%/42%.

  Comparison

  PICC P&C had the best combined ratio among the major P&C insurers cited.

  Risks

  Potentially higher 2H26 natural-catastrophe losses.

• China Pacific Insurance (CPIC)

  Tactically preferred counter-cyclical name in Citi’s sector view.

  Strengths

  Life NBV rose 13%; P&C combined ratio improved 1.3 percentage points to 95.0%; the group introduced an interim dividend.

  Weaknesses

  Life NBV growth was mainly margin-driven despite first-year-premium contraction.

  Comparison

  Its P&C combined ratio was below PICC P&C’s 94.0% but above Ping An P&C’s 95.1% on the reported figures.

  Risks

  High 3Q26 comparison base, short-term bancassurance disruption and potential natural-catastrophe losses.

Key data

• China Life 1H26 NBV growth34% yoyHighest among the listed life insurers discussed.
• CPIC / New China Life / Ping An 1H26 NBV growth13% / 12% / 11% yoyBroadly decent life-insurance new-business growth.
• PICC / CPIC / Ping An P&C combined ratio94.0% / 95.0% / 95.1%Further year-on-year underwriting improvement.
• China Life earnings growth229% yoySupported primarily by higher investment gains.
• China Taiping FY26E/FY27E/FY28E EPS revisions+39% / +23% / +13%Reflects higher investment-return estimates.
• China Taiping target priceHK$23.00 from HK$22.50Neutral rating retained; price was HK$21.96 on 1 September 2026.

Impact & implications

Citi sees stronger life margins, P&C underwriting discipline and investment gains as supportive of 1H26 results. It cautions that 3Q26 growth may soften because of a high comparison base and bancassurance disruption, while identifying long-term insurance demand and regulatory reforms as the sector’s principal support. The report tactically prefers PICC and CPIC among counter-cyclical names.

Risks

• For China Taiping, Citi cites continuing bond-yield declines, a sharp A-share correction, earnings or NBV disappointment, slower life-business recovery, management-execution risk, slower expansion and severe catastrophe losses in P&C and reinsurance.
• Citi expects natural-catastrophe losses to potentially worsen year on year in 2H26 amid El Niño.
• Life-insurance growth may be pressured by a high 3Q26 comparison base and short-term disruption from bancassurance expense rationalization.

What to watch

• 3Q26 life-insurance growth against the elevated base created by pre-rate-cap-cut sales in 3Q25.
• The effect of further bancassurance expense rationalization on sales and margins after July 2026.
• P&C combined-ratio trends, including catastrophe losses and the effect of regulatory expense reforms.
• Investment returns and the contribution of market gains to insurers’ earnings.
• China Taiping’s delivery against higher investment-return assumptions and NBV and earnings expectations.